Aldar A. Munkuev
Severnij Pr. 1
Chernogolovka, MOS 142432, Russian Federation
Chernogolovka, MOS 142432, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neuroprotective Potential of New Monoterpene-Adamatane Conjugates-A Pilot Study.
Journal: Current issues in molecular biology
Published: December 22, 2025
Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance.
Journal: Cancers
Published: August 30, 2023
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer's Disease Based on Novel Monoterpene-Derived Hydroxamic Acids.
Journal: International journal of molecular sciences
Published: April 26, 2023
New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.
Journal: Molecules (Basel, Switzerland)
Published: July 28, 2022
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.
Journal: Molecules (Basel, Switzerland)
Published: April 29, 2022
Novel Bispidine-Monoterpene Conjugates-Synthesis and Application as Ligands for the Catalytic Ethylation of Chalcones.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2021
Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer's Disease: Synthesis, Docking and Biological Evaluation.
Journal: Pharmaceutics
Published: October 11, 2021
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.
Journal: Molecules (Basel, Switzerland)
Published: April 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026